Hua Medicine Turns to 2025 Profit; Shares Soar 10%

MT Newswires Live

03/27

Hua Medicine (Shanghai) (HKG:2552) recorded a profit of 1.11 billion yuan in 2025, compared with a loss of 250.1 million yuan a year prior, according to a Thursday Hong Kong bourse filing.

Shares of the Chinese drugmaker were up over 10% in Friday afternoon trading.

Earnings per share stood at 1.10 yuan for the period, compared with a loss per share of 0.25 yuan in the previous fiscal year.

The pharmaceutical company's revenue surged to 492.9 million yuan from 255.9 million yuan previously, generated mainly from the sale of core product HuaTangNing.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2622846835"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2622846835\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2622846835?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 15:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622846835","market":"us","top_or_hot":-1,"title":"Hua Medicine Turns to 2025 Profit; Shares Soar 10%","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/HUMDF\">Hua Medicine</a> (Shanghai) (HKG:2552) recorded a profit of 1.11 billion yuan in 2025, compared with a loss of 250.1 million yuan a year prior, according to a Thursday Hong Kong bourse filing.</p><p>Shares of the Chinese drugmaker were up over 10% in Friday afternoon trading.</p><p>Earnings per share stood at 1.10 yuan for the period, compared with a loss per share of 0.25 yuan in the previous fiscal year.</p><p>The pharmaceutical company's revenue surged to 492.9 million yuan from 255.9 million yuan previously, generated mainly from the sale of core product HuaTangNing.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hua Medicine Turns to 2025 Profit; Shares Soar 10%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHua Medicine Turns to 2025 Profit; Shares Soar 10%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-27 15:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/HUMDF\">Hua Medicine</a> (Shanghai) (HKG:2552) recorded a profit of 1.11 billion yuan in 2025, compared with a loss of 250.1 million yuan a year prior, according to a Thursday Hong Kong bourse filing.</p><p>Shares of the Chinese drugmaker were up over 10% in Friday afternoon trading.</p><p>Earnings per share stood at 1.10 yuan for the period, compared with a loss per share of 0.25 yuan in the previous fiscal year.</p><p>The pharmaceutical company's revenue surged to 492.9 million yuan from 255.9 million yuan previously, generated mainly from the sale of core product HuaTangNing.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02552","symbol_name":"华领医药-B","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2622846835","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2622846835","pubTimestamp":1774598343,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Hua Medicine   recorded a profit of 1.11 billion yuan in 2025, compared with a loss of 250.1 million yuan a year prior, according to a Thursday Hong Kong bourse filing.Shares of the Chinese drugmaker were up over 10% in Friday afternoon trading.Earnings per share stood at 1.10 yuan for the period, compared with a loss per share of 0.25 yuan in the previous fiscal year.The pharmaceutical company's revenue surged to 492.9 million yuan from 255.9 million yuan previously, generated mainly from the sale of core product HuaTangNing.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02552":"华领医药-B","BK1191":"制药","HUMDF":"Hua Medicine","BK1574":"生物医药B类股","BK4007":"制药"},"translate_title":"华领医药转2025年盈利；股价飙升10%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HUMDF":1.5,"02552":1},"content_text":"Hua Medicine (Shanghai) (HKG:2552) recorded a profit of 1.11 billion yuan in 2025, compared with a loss of 250.1 million yuan a year prior, according to a Thursday Hong Kong bourse filing.Shares of the Chinese drugmaker were up over 10% in Friday afternoon trading.Earnings per share stood at 1.10 yuan for the period, compared with a loss per share of 0.25 yuan in the previous fiscal year.The pharmaceutical company's revenue surged to 492.9 million yuan from 255.9 million yuan previously, generated mainly from the sale of core product HuaTangNing.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}